Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Seehofer

Showing results (21-30 of 310) with videos related to

Pageof 31
Sort By:
Clinical Nuclear Medicine|January 21, 2006
Incidental parathyroid adenoma mimicking tumor recurrence in a patient with follicular thyroid carcinomaJuri Ruf, Daniel Seehofer, Bahram Nadjari, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 10, 2025
Ex vivo Drug Metabolism Using Primary Human Hepatocytes for the Detection of Metabolite-Dependent Antibodies to Red Blood CellsBeate Mayer, Florian Kurth, Georg Damm, et al.
Kidney International|September 24, 2019
The Case | Atypical cysts in a patient with autosomal dominant polycystic kidney diseaseHenning Trawinski, Thomas Karlas, Daniel Seehofer, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 8, 2016
Cell sources for in vitro human liver cell culture modelsKatrin Zeilinger, Nora Freyer, Georg Damm, et al.
Journal of Cancer Research and Clinical Oncology|October 25, 2025
Intrahepatic cholangiocarcinoma as a unique subtype: key updates from current guidelinesAaron Schindler, Timm Denecke, Daniel Seehofer, et al.
Surgical Technology International|August 23, 2021
Current State and Future Possibilities in Liver TransplantationSebastian Rademacher, Niklas F Aehling, Robert Sucher, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|January 29, 2016
Risk factors for bile leakage after hepatectomyBenjamin Struecker, Andreas Andreou, Igor M Sauer, et al.
Molecules (Basel, Switzerland)|March 6, 2021
Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic SteatosisLena Seidemann, Anne Krüger, Victoria Kegel-Hübner, et al.
Journal of Hepatology|December 18, 2023
Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD scoreMagdalena Hahn, Adam Herber, Thomas Berg, et al.
Hepatobiliary Surgery and Nutrition|March 2, 2023
The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumabSabine Lieb, Sebastian Ebel, Daniel Seehofer, et al.
Pageof 31

Showing results (21-30 of 310) with videos related to

Sort By:
Pageof 31
Clinical Nuclear Medicine|January 21, 2006
Incidental parathyroid adenoma mimicking tumor recurrence in a patient with follicular thyroid carcinomaJuri Ruf, Daniel Seehofer, Bahram Nadjari, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 10, 2025
Ex vivo Drug Metabolism Using Primary Human Hepatocytes for the Detection of Metabolite-Dependent Antibodies to Red Blood CellsBeate Mayer, Florian Kurth, Georg Damm, et al.
Kidney International|September 24, 2019
The Case | Atypical cysts in a patient with autosomal dominant polycystic kidney diseaseHenning Trawinski, Thomas Karlas, Daniel Seehofer, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 8, 2016
Cell sources for in vitro human liver cell culture modelsKatrin Zeilinger, Nora Freyer, Georg Damm, et al.
Journal of Cancer Research and Clinical Oncology|October 25, 2025
Intrahepatic cholangiocarcinoma as a unique subtype: key updates from current guidelinesAaron Schindler, Timm Denecke, Daniel Seehofer, et al.
Surgical Technology International|August 23, 2021
Current State and Future Possibilities in Liver TransplantationSebastian Rademacher, Niklas F Aehling, Robert Sucher, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|January 29, 2016
Risk factors for bile leakage after hepatectomyBenjamin Struecker, Andreas Andreou, Igor M Sauer, et al.
Molecules (Basel, Switzerland)|March 6, 2021
Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic SteatosisLena Seidemann, Anne Krüger, Victoria Kegel-Hübner, et al.
Journal of Hepatology|December 18, 2023
Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD scoreMagdalena Hahn, Adam Herber, Thomas Berg, et al.
Hepatobiliary Surgery and Nutrition|March 2, 2023
The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumabSabine Lieb, Sebastian Ebel, Daniel Seehofer, et al.
Pageof 31